Greenwich LifeSciences GLSI
NASDAQ GLSI
$18.38 -0.21 (-1.13%)
At close: Sep 29, 2026 · 4:00 PM EDT

Greenwich LifeSciences (GLSI) Total Current Liabilities (2019 - 2026)

Updated

Greenwich LifeSciences (GLSI) reported Total Current Liabilities of $5.24 million for Q1 2026, up 263.9% from $1.44 million a year earlier but down 10.1% from the prior quarter.

Analysis

Greenwich LifeSciences (GLSI) Total Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Greenwich LifeSciences posted Total Current Liabilities of $5.82 million, up 82.9% from FY2024.

  • Total Current Liabilities has increased for three consecutive years, with a five-year compound annual growth rate of 41.0% (FY2020 to FY2025).
  • By year, Total Current Liabilities came in at $3.19 million in FY2024 (+981.9%), $294,406 in FY2023 (+12.0%), $262,905 in FY2022 (-31.7%) and $385,172 in FY2021 (-63.2%).
  • Five-year quarterly Total Current Liabilities spans a low of $229,134 in Q2 2022 and a high of $5.82 million in Q4 2025.
  • Year over year, Total Current Liabilities has now increased in each of the last 12 quarters, with growth averaging 280.9% over the last eight quarters.
  • The high point for year-over-year Total Current Liabilities in five years was Q4 2024 (growth of 981.9%); the low point was Q3 2021 (a decline of 71.8%).
  • Per Business Quant data, the three quarters before Q1 2026 came in at $5.82 million (Q4 2025), $1.62 million (Q3 2025) and $1.69 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Greenwich LifeSciences 272.64 Mn 272.64 Mn - 5.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 5.24 Mn
Dec 31, 2025 5.82 Mn
Sep 30, 2025 1.62 Mn
Jun 30, 2025 1.69 Mn
Mar 31, 2025 1.44 Mn
Dec 31, 2024 3.19 Mn
Sep 30, 2024 842,384.00
Jun 30, 2024 1.35 Mn
Mar 31, 2024 389,611.00
Dec 31, 2023 294,406.00
Sep 30, 2023 297,287.00
Jun 30, 2023 301,546.00
Mar 31, 2023 235,575.00
Dec 31, 2022 262,905.00
Sep 30, 2022 237,879.00
Jun 30, 2022 229,134.00
Mar 31, 2022 241,168.00
Dec 31, 2021 385,172.00
Sep 30, 2021 455,119.00
Jun 30, 2021 652,594.00
API Access

Greenwich LifeSciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=GLSI&period=max&api_key=YOUR_API_KEY